* Sanara Medtech Inc SMTI.OQ reported a quarterly adjusted
loss
of 22 cents per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 13 cents per
share.
* Revenue rose 62.9% to $15.75 million from a year ago;
analysts
expected $16.90 million.
* Sanara Medtech Inc's reported EPS for the quarter was a
loss
of 22 cents.
* The mean earnings estimate of analysts had risen by
about 50% in
the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Sanara Medtech Inc shares had risen by 14.7% this
quarter and
gained 1.1% so far this year.
* The company reported a quarterly loss of $1.83 million.
* Wall Street's median 12-month price target for Sanara
Medtech
Inc is $59.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 14 at 09:02 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.13 -0.22 Missed
Mar. 31 2023 -0.33 -0.14 Beat
Dec. 31 2022 -0.26 -0.38 Missed
Sep. 30 2022 -0.32 -0.18 Beat